PrimeCuts

Primecuts – This Week in the Journals

July 19, 2010
Primecuts – This Week in the Journals

By David Veal, MD

Faculty Peer Reviewed

Recent international intrigue–replete with secret identities and coded messages–reached a dénouement when ten Russian agents were exchanged for four Americans in Vienna and an Iranian scientist residing in the US repatriated.  Despite our popular culture’s fascination with clandestine politics, these events unfolded without the panache that comes with ordering a martini shaken, not stirred, or the quixotic mojo of a certain Austin “Danger” Powers.  Instead, with much speculation about what lies ahead…

Read more »

Primecuts – This Week in the Journals

July 12, 2010
Primecuts – This Week in the Journals

By Dana Clutter, MD

Faculty Peer Reviewed

 As HIV/AIDS researchers around the world prepare for the upcoming 18th International AIDS Conference in Vienna from July 18-23, the HIV/AIDS epidemic has been in the spotlight. We begin with an encouraging report that the Obama administration has pledged an extra $25 million to the AIDS Drug Assistance Program (ADAP) . Anxiety surrounding the placement of more and more HIV-infected Americans on record-length waitlists for ART (now totaling 2100 patients across 11…

Read more »

Primecuts – This Week in the Journals

July 6, 2010
Primecuts – This Week in the Journals

By David Hormozdi, MD

Faculty Peer Reviewed

Ah July! A time filled with backyard barbeques, family vacations, and fireworks.  But for new attendings, fellows, and housestaff across the country, July 1 marks the start of added responsibility, trepidation, and autonomy.  With the added responsibility comes the age-old phrase – do no harm – and in this weeks Primecuts we explore controversial medications that may be doing little good for our patients.  This week we will take another look at…

Read more »

Primecuts-This Week in the Journals

June 28, 2010
Primecuts-This Week in the Journals

Michael Fingerhood, MD, MPH

Faculty Peer Reviewed

Ah, the long balmy days of summer in New York, replete with dining al fresco, Shakespeare in The Park, bumper-to-bumper traffic to our pristine (for now, at least) local beaches, and of course the armies of fresh-faced, eager young Housestaff  proudly marching through the wards in their new long white coats. July 1st quickly approaches, and with it NYU’s new interns (myself included) excitedly begin their vital role within the nation’s healthcare…

Read more »

Primecuts: This Week In The Journals

June 21, 2010
Primecuts: This Week In The Journals

By Jeffrey Mayne, MD

Faculty Peer Reviewed

PRIMECUTS!  PRIMECUTS!  As the excitement of the World Cup rolls on and the din of those vuvuzela horns continues to ring heavy in your ears, the Wall Street Journal reports the horns once used to rally people in remote places, now used to champion athletes, may have lasting effects .  The vuvuzela is traditionally made from the horn of a kudu, a species of antelope found in Africa and was first used…

Read more »

Primecuts: This Week In The Journals

June 14, 2010
Primecuts: This Week In The Journals

By Maryann Kwa, MD

Faculty Peer Reviewed

This week, ecstatic soccer fans around the world are gathering to watch the excitement and celebrate the camaraderie that is the World Cup.  As the enthusiasm reaches a fever pitch in South Africa–the first country on the continent to host the games–the competitive spirit amongst players and fans is surely running high.  Speaking of competition, we start this edition of Primecuts with a very interesting piece in The New York Times about…

Read more »

Primecuts: This Week In The Journals

June 7, 2010
Primecuts: This Week In The Journals

By Todd Cutler, MD

Faculty Peer Reviewed

Summer is here and the only thing hotter than the weather is this week’s edition of Primecuts. In an early online publication this week in Lancet , the authors of the CANOE (Canadian Normoglycemia Outcomes Evaluation) study evaluated the efficacy of rosiglitazone and metformin in preventing progression to type 2 diabetes in patients with impaired glucose tolerance. In previous studies, both drugs had individually been shown to be effective in preventing progression to diabetes in high-risk patients,…

Read more »

Primecuts: This Week In The Journals

June 1, 2010
Primecuts: This Week In The Journals

By Mario Fusaro, MD

Faculty Peer Reviewed

We begin this week’s Memorial Day edition of Primecuts by taking a moment to recognize the service men and women of our country.  As people celebrated the holiday weekend with barbeques and beach trips, we should not lose sight of its main significance, to honor those charged with protecting our way of life.  While the veteran population ages, they look to us to protect their health as they once protected our freedoms.  …

Read more »

Primecuts: This Week in the Journals

May 24, 2010
Primecuts: This Week in the Journals

By Mary Whitman, MD

Faculty Peer Reviewed

We start this week with news that the American Heart Association (AHA) is teaming up with Nintendo of America to promote its “active gaming” Wii console and games, such as WiiFit.  While some argue that the AHA should be promoting more energetic exercise, we agree with their statement, “Participating in an actual sport is usually more vigorous than active gaming, but active gaming compares very well with sitting on the couch.”  As…

Read more »

Primecuts: This Week In The Journals

May 17, 2010
Primecuts: This Week In The Journals

Brandon Oberweis, MD

Faculty Peer Reviewed

 This week’s edition of Primecuts begins with President Obama’s recent nomination of Elena Kagan, the current Solicitor General of the United States, as the 112th Supreme Court Justice.  If confirmed, Kagan would join Ruth Bader Ginsburg and Sonia Sotomayor as the third female justice on the bench.  Frank Sinatra once sang in his tribute to New York, “If I can make it there, I can make it anywhere…” And right he was.  Interestingly,…

Read more »

Primecuts – This Week in the Journals

May 10, 2010
Primecuts – This Week in the Journals

Michael Tanner, MD  Associate Editor, Clinical Correlations

Hemoglobin Targets in Chronic Kidney Disease

Approved by the FDA in 1989, the success of erythropoietin in patients with chronic kidney disease and transfusion-dependent anemia led to trials testing the possible benefits of  progressively higher hemoglobin targets.   This week’s Annals of Internal Medicine (1) features a systematic review by Palmer et al of 27 trials of erythropoietin and darbepoietin titrated to various hemoglobin targets.  The review concludes that  hemoglobin targets of >13.0 g/L are associated with increased…

Read more »

Primecuts-This Week in the Journals

May 3, 2010
Primecuts-This Week in the Journals

 The 21st Running of the City of Pittsburgh Marathon

 Michael Ford, MD

Faculty Peer Reviewed

I am filing this dispatch from Pittsburgh, Pennsylvania.  A former home of steel, bratwurst, Iron City Beer, and cigarettes, Pittsburgh today finds itself lurching somewhat awkwardly along a transitional path toward gleaming healthcare and biotech excellence.  This location seems appropriate, as it was home to me for 10 years prior to relocating to NYC to begin a medical career.  It was here…

Read more »